Are you Dr. Kornbluth?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 42 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3030 Bunker Hill St
Ste 115B
San Diego, CA 92109Phone+1 619-846-8603Fax+1 858-456-7436
Summary
- Dr. Richard Kornbluth, MD is a pulmonologist in San Diego, California. He is currently licensed to practice medicine in California.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Fellowship, Pulmonary Disease and Critical Care Medicine, 1978 - 1982
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1975 - 1978
New York Medical CollegeClass of 1975
Certifications & Licensure
CA State Medical License 1983 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 35 citationsGeneration and Characterization of Alloantigen-Specific Regulatory T Cells For Clinical Transplant Tolerance.James M. Mathew, Jessica H. Voss, Scott T. McEwen, Iwona M. Konieczna, Arjun Chakraborty
Scientific Reports. 2018-01-18 - 16 citationsHIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4-1BBL enhance T cell mediated anti-viral immunity.Saravana Kanagavelu, James M. Termini, Sachin Gupta, Francesca N. Raffa, Katherine A. Fuller
Plos One. 2014-02-28 - 9 citationsVaccination with a Fusion Protein That Introduces HIV-1 Gag Antigen into a Multitrimer CD40L Construct Results in Enhanced CD8+ T Cell Responses and Protection from Vi...Sachin Gupta, James M. Termini, Francesca N. Raffa, Cindi Ann Williams, Richard S. Kornbluth
Journal of Virology. 2014-02-01
Grant Support
- Precision Immunization Vaccine For Nicotine And Other Drugs Of AbuseNational Institute On Drug Abuse2010–2011
- Vaccines To Generate Neutralizing Anti-Hiv AntibodiesNational Institute Of Allergy And Infectious Diseases2007–2008
- Combined Tnfsf And TLR Stimulation Of HIV VaccinesNational Institute Of Allergy And Infectious Diseases2005–2006
- Tnfsf APC Activators For HIV VaccinesNational Institute Of Allergy And Infectious Diseases2002–2003
- Regulation Of HIV-1 Preintegration Complexes (PICS)National Institute Of Allergy And Infectious Diseases2002
- Core--Viral PathogenesisNational Institute Of Allergy And Infectious Diseases1998–2001
- Immune And Therapeutic Suppression Of HIV In The LungNational Heart, Lung, And Blood Institute1996–2000
- Core--VirologyNational Institute Of Allergy And Infectious Diseases1994–1997
- Macrophage-Tuberculosis Interactions--Functional EffectsNational Institute Of Allergy And Infectious Diseases1993–1997
- Alveolar Macrophages And Defense Of The Lung In AIDSNational Heart, Lung, And Blood Institute1989–1993
- HIV Effects On T Cell Activation Of Macrophage FunctionsNational Institute Of Allergy And Infectious Diseases1987–1993
- HIV Effects Of T Cell Activation Of Macrophage FunctionsNational Institute Of Allergy And Infectious Diseases1991–1992
- HIV, Macrophages, And Other Non-Lymphocytic CellsNational Institute Of Allergy And Infectious Diseases1989
